Detalhe da pesquisa
1.
Baseline Seroprevalence of SARS-CoV-2 Specific Antibodies in Hot Spot Areas of Great Tunis, up to 3 Months Post Disease Onset in Tunisia.
Epidemiologia (Basel)
; 4(2): 188-201, 2023 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37367185
2.
Impact of contact tracing, respect of isolation, and lockdown in reducing the number of cases infected with COVID-19. Case study: Tunisia's response from March 22 to May 4, 2020.
Int J Infect Dis
; 113: 26-33, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33578008
3.
Antiretroviral therapy needs: the effect of changing global guidelines.
Sex Transm Infect
; 86 Suppl 2: ii62-6, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21106517
4.
Changes in antiretroviral therapy guidelines: implications for public health policy and public purses.
Sex Transm Infect
; 86(5): 388-90, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20876757
5.
Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy.
Sex Transm Infect
; 86 Suppl 2: ii28-34, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21106512
6.
Leveraging Global Fund investments for health systems strengthening: a qualitative case study on Morocco's Concept Note development.
East Mediterr Health J
; 26(8): 957-966, 2020 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32896891
7.
Investment in HIV/AIDS programs: does it help strengthen health systems in developing countries?
Global Health
; 4: 8, 2008 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-18796148
8.
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.
Lancet
; 368(9534): 505-10, 2006 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-16890837
9.
National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?
AIDS
; 20(11): 1497-502, 2006 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-16847404
10.
To retain or remove user fees?: reflections on the current debate in low- and middle-income countries.
Appl Health Econ Health Policy
; 5(3): 137-53, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17132029
11.
Beyond indicators: advances in global HIV monitoring and evaluation during the PEPFAR era.
J Acquir Immune Defic Syndr
; 60 Suppl 3: S120-6, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22797733
12.
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050.
PLoS One
; 7(2): e30216, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22348000
13.
Integrated surveillance of HIV care in low-income and middle-income countries.
Curr Opin HIV AIDS
; 6(4): 233-8, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21519245
14.
Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countries.
AIDS Res Treat
; 2011: 749041, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21490783
15.
Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis.
Curr HIV Res
; 9(6): 355-66, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21999771
16.
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update.
Curr Opin HIV AIDS
; 5(4): 298-304, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20543604
17.
Estimation of antiretroviral therapy coverage: methodology and trends.
Curr Opin HIV AIDS
; 5(1): 97-102, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20046154
18.
Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries.
J Acquir Immune Defic Syndr
; 54(4): 437-41, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20351559
19.
Evaluation of three sampling methods to monitor outcomes of antiretroviral treatment programmes in low- and middle-income countries.
PLoS One
; 5(11): e13899, 2010 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21085709
20.
Highly active antiretroviral treatment for the prevention of HIV transmission.
J Int AIDS Soc
; 13: 1, 2010 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20205768